AskBio strengthens its gene therapy technology portfolio

AskBio Strengthens its Gene Therapy Technology Portfolio Asklepios Biopharmaceutical (AskBio), a US clinical-stage gene therapy platform company dedicated to rare genetic disorders, is currently expanding its technological capabilities. This AAV gene therapy company has now acquired Synpromics, a UK-based leader in gene  control synthetic promoter technology, bioinformatics and intelligent data-driven design…..